South Australian Medicines Evaluation Panel (SAMEP)
Evaluate High Cost Medicines used in South Australian public hospitals for safety, clinical efficacy and cost-effectiveness.
If a high cost medicine:
apply directly to your local hospital Drug and Therapeutics Committee (DTC), or equivalent committee, for individual patient use (IPU) of the medicine.
Applications (PDF 1118KB) to use a high cost medicine in an individual patient must be forwarded directly to your local hospital DTC, or equivalent committee, for individual patient use of the medicine.
Where there are less than three applications across the state for the same drug, for the same condition, your local DTC can authorise these requests.
Once three IPU requests for a high cost medicine have been approved for a particular condition within SA public hospitals, further IPU requests must be referred to the Department for Health and Ageing for approval, through your DTC.
For medicines which have reached the "3-IPU threshold", a formulary application should be completed and forwarded, via the hospital DTC, to the South Australian Medicines Evaluation Panel (SAMEP) for evaluation. More information on this is available on the High cost medicines formulary page.
For further information on individual patient use of high cost medicines, contact the Executive Officer for South Australian Medicines Evaluation Panel.